Replies to post #143737 on OWC Pharmaceutical Research Corp (OWCP)

[I-Glow]

The up to 47,500,000 means that is the amount of shares DGF receives if they fund the full $5 Million.

I have no idea why that is so difficult to understand - DGF doesn't have to fund the entire $5 Million - if they do they recieve 47,500,000 million shares.

You posted:

OWCP will then pay Newbridge a commission on the proceeds from exercised Warrants of 4% which is $110,000.

From the 424B3 we find the following: "The Warrants contain customary terms, including provisions for “cashless” exercise, change of control, price based anti-dilution, and customary demand or piggyback registration rights. In addition, we are obligated to pay Newbridge a warrants solicitation fee equal to 4% of the gross proceeds that we receive upon cash exercise of the Warrants."

Newbridge doesn't have to pay anything as it is a cashless exercise - they just received the money.

I didn't include the 4% in the $11+ Million for the $5 million toxic loan.

You really lack a understanding of warrants - I suggest you read the Equity Purchase Agreement.

You didn't include the entire 47,500,000 shares in your calculations - you only used the warrants for some reason which is meaningless when you are calculating the cost of the $5 million toxic loan.

Just for your edification the 4% of the gross proceeds from the warrants - hold on here we go: Let's use your $0.20 number - (12,500,000 x 0.2) x 4% = $100,000!

Newbridge receives a unheard of finders fee of 2,500,00 x $0.20 = $500,000 Plus $375,000 Plus $100,000 ....

For a grand total of $975,000

That is 19.5% of the $5 million loan.

IG